177 related articles for article (PubMed ID: 35306431)
1. Neutrophil extracellular traps (NETs) in patients with STEMI. Association with percutaneous coronary intervention and antithrombotic treatments.
Ferré-Vallverdú M; Latorre AM; Fuset MP; Sánchez E; Madrid I; Ten F; Vallés J; Santos MT; Bonanad S; Moscardó A
Thromb Res; 2022 May; 213():78-83. PubMed ID: 35306431
[TBL] [Abstract][Full Text] [Related]
2. Culprit site extracellular DNA and microvascular obstruction in ST-elevation myocardial infarction.
Mangold A; Ondracek AS; Hofbauer TM; Scherz T; Artner T; Panagiotides N; Beitzke D; Ruzicka G; Nistler S; Wohlschläger-Krenn E; Winker R; Quehenberger P; Traxler-Weidenauer D; Spannbauer A; Gyöngyösi M; Testori C; Lang IM
Cardiovasc Res; 2022 Jun; 118(8):2006-2017. PubMed ID: 34173822
[TBL] [Abstract][Full Text] [Related]
3. 16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction.
Thrane PG; Kristensen SD; Olesen KKW; Mortensen LS; Bøtker HE; Thuesen L; Hansen HS; Abildgaard U; Engstrøm T; Andersen HR; Maeng M
Eur Heart J; 2020 Feb; 41(7):847-854. PubMed ID: 31504424
[TBL] [Abstract][Full Text] [Related]
4. Short-term efficacy of angiotensin receptor-neprilysin inhibitor treatment in patients with ST-segment elevation myocardial infarction with reduced ejection fraction after primary percutaneous coronary intervention: a propensity score matching study.
Zhang Q; Qiao B; Han Y; Sun S; Wang B; Wei S
BMC Cardiovasc Disord; 2022 Nov; 22(1):463. PubMed ID: 36333668
[TBL] [Abstract][Full Text] [Related]
5. Deoxyribonuclease 1 Q222R single nucleotide polymorphism and long-term mortality after acute myocardial infarction.
Hofbauer TM; Mangold A; Ondracek AS; Panzenböck A; Scherz T; Müller J; Distelmaier K; Seidl V; Kastl S; Müller-Nurasyid M; Peters A; Strauch K; Winker R; Wohlschläger-Krenn E; Nistler S; Lang IM
Basic Res Cardiol; 2021 Apr; 116(1):29. PubMed ID: 33891165
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
7. Relationship between TRAIL and Left Ventricular Ejection Fraction in Patients with ST-Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention.
Teringova E; Kozel M; Knot J; Kocka V; Benesova K; Tousek P
Biomed Res Int; 2018; 2018():3709084. PubMed ID: 30112383
[TBL] [Abstract][Full Text] [Related]
8. Impact of pre-angioplasty antithrombotic therapy administration on coronary reperfusion in ST-segment elevation myocardial infarction: Does time matter?
Giralt T; Ribas N; Freixa X; Sabaté M; Caldentey G; Tizón-Marcos H; Carrillo X; García-Picart J; Lidón RM; Cárdenas M; Pérez-Fernández S; Mauri J; Vaquerizo B
Int J Cardiol; 2021 Feb; 325():9-15. PubMed ID: 32991944
[TBL] [Abstract][Full Text] [Related]
9. ST-elevation myocardial infarction with reduced left ventricular ejection fraction: Insights into persisting left ventricular dysfunction. A pPCI-registry analysis.
Stolfo D; Cinquetti M; Merlo M; Santangelo S; Barbati G; Alonge M; Vitrella G; Rakar S; Salvi A; Perkan A; Sinagra G
Int J Cardiol; 2016 Jul; 215():340-5. PubMed ID: 27128558
[TBL] [Abstract][Full Text] [Related]
10. Role of ST-Segment Resolution in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the 5-Year Outcomes of the EXAMINATION [Evaluation of the Xience-V Stent in Acute Myocardial Infarction] Trial).
Spitaleri G; Brugaletta S; Scalone G; Moscarella E; Ortega-Paz L; Pernigotti A; Gomez-Lara J; Cequier A; Iñiguez A; Serra A; Jiménez-Quevedo P; Mainar V; Campo G; Tespili M; den Heijer P; Bethencourt A; Vazquez N; Valgimigli M; Serruys PW; Sabaté M
Am J Cardiol; 2018 May; 121(9):1039-1045. PubMed ID: 29544865
[TBL] [Abstract][Full Text] [Related]
11. Outcomes after delayed primary percutaneous coronary intervention vs. pharmaco-invasive strategy in ST-segment elevation myocardial infarction in Norway.
Jortveit J; Pripp AH; Halvorsen S
Eur Heart J Cardiovasc Pharmacother; 2022 Aug; 8(5):442-451. PubMed ID: 34038535
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y
J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809
[TBL] [Abstract][Full Text] [Related]
13. [Effect of thrombus aspiration during primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction].
Shen C; Wang LF
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Jan; 47(1):49-55. PubMed ID: 30669810
[No Abstract] [Full Text] [Related]
14. Time-of-day at symptom onset was not associated with infarct size and long-term prognosis in patients with ST-segment elevation myocardial infarction.
Sager HB; Husser O; Steffens S; Laugwitz KL; Schunkert H; Kastrati A; Ndrepepa G; Kessler T
J Transl Med; 2019 May; 17(1):180. PubMed ID: 31142323
[TBL] [Abstract][Full Text] [Related]
15. Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmaco-invasive strategy in ST-segment elevation myocardial infarction: the FAST-MI programme.
Danchin N; Popovic B; Puymirat E; Goldstein P; Belle L; Cayla G; Roubille F; Lemesle G; Ferrières J; Schiele F; Simon T;
Eur Heart J; 2020 Feb; 41(7):858-866. PubMed ID: 31539043
[TBL] [Abstract][Full Text] [Related]
16. Parenteral antithrombotic therapy during primary percutaneous coronary intervention.
Fortuni F; Ferlini M; Leonardi S
Minerva Cardioangiol; 2018 Aug; 66(4):411-421. PubMed ID: 29393605
[TBL] [Abstract][Full Text] [Related]
17. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
[No Abstract] [Full Text] [Related]
18. Efficacy and safety of bivalirudin application during primary percutaneous coronary intervention in older patients with acute ST-segment elevation myocardial infarction.
Chen H; Yu X; Kong X; Li L; Wu J; Ma L
J Int Med Res; 2020 Sep; 48(9):300060520947942. PubMed ID: 32985292
[TBL] [Abstract][Full Text] [Related]
19. Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study.
Shavadia J; Welsh R; Gershlick A; Zheng Y; Huber K; Halvorsen S; Steg PG; Van de Werf F; Armstrong PW
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 28525886
[TBL] [Abstract][Full Text] [Related]
20. Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry.
Jovin IS; Shah RM; Patel DB; Rao SV; Baklanov DV; Moussa I; Kennedy KF; Secemsky EA; Yeh RW; Kontos MC; Vetrovec GW
JACC Cardiovasc Interv; 2017 Jun; 10(11):1102-1111. PubMed ID: 28527778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
